HNGZY (Hangzhou Tigermed Consulting Co) Sale Of Investment : $167.1 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Sale Of Investment?

Hangzhou Tigermed Consulting Co's sale of investment for the three months ended in Sep. 2024 was $49.8 Mil. It means Hangzhou Tigermed Consulting Co gained $49.8 Mil from selling investments. Hangzhou Tigermed Consulting Co's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $167.1 Mil.

Compared with last quarter ($19.0 Mil in Jun. 2024 ), Hangzhou Tigermed Consulting Co gained more money from selling investments in Sep. 2024 ($49.8 Mil).

Hangzhou Tigermed Consulting Co Sale Of Investment Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Sale Of Investment Chart

Hangzhou Tigermed Consulting Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

73.44

160.41

166.84

61.72

170.50

Hangzhou Tigermed Consulting Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Sale Of Investment	Get a 7-Day Free Trial															43.28	75.72	22.54	18.97	49.83

Hangzhou Tigermed Consulting Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $167.1 Mil.

Hangzhou Tigermed Consulting Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (OTCPK:HNGZY) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

03347:Hong Kong 5HZ1:Germany 300347:China

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.